We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
AnteoTech is a biotechnology business based in Australia. AnteoTech shares (ADO) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. AnteoTech has a trailing 12-month revenue of around $2.9 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Overall broker
Our top pick for
Low-cost broker
| 52-week range | $0.055 - $0.415 |
|---|---|
| 50-day moving average | $0.0999 |
| 200-day moving average | $0.1827 |
| Target price | $0.38 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.004 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.066
| 1 week (2022-06-24) | 0.066 |
|---|---|
| 1 month (2022-06-02) | -33.33% |
| 3 months (2022-04-01) | -42.61% |
| 6 months (2021-12-31) | -78.36% |
| 1 year (2021-07-02) | -74.62% |
|---|---|
| 2 years (2020-07-02) | 214.29% |
| 3 years (2019-07-02) | 348.98% |
| 5 years (2017-06-30) | 340.00% |
| Revenue TTM | $2.9 million |
|---|---|
| Gross profit TTM | $2.3 million |
| Return on assets TTM | -38.78% |
| Return on equity TTM | -69.72% |
| Profit margin | -297.12% |
| Book value | 0.009 |
| Market capitalisation | $149.1 million |
TTM: trailing 12 months
We're not expecting AnteoTech to pay a dividend over the next 12 months.
AnteoTech's shares were split on 23 September 2009.
Over the last 12 months, AnteoTech's shares have ranged in value from as little as $0.055 up to $0.415. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while AnteoTech's is 1.4287. This would suggest that AnteoTech's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. The company's products include AnteoCoat, which comprise a suite of compounds that enable the control of material interactions and properties in the energy storage applications; AnteoBind ready-to-use kits to streamline and improve the conjugation process; and EuGeni, a COVID-19 antigen rapid test. It has collaboration agreements with Axxin for COVID-19 anigen test. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited was incorporated in 1995 and is headquartered in Eight Mile Plains, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
